Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission
Institute of Liver and Biliary Sciences · The University of Sydney · +19 more institutions
Abstract
The Asia-Pacific region is home to more than half of the global population and accounted for 62·6% of global deaths due to liver diseases in 2015. 54·3% of global deaths due to cirrhosis, 72·7% of global deaths due to hepatocellular carcinoma, and more than two-thirds of the global burden of acute viral hepatitis occurred in this region in 2015. Chronic hepatitis B virus (HBV) infection caused more than half of the deaths due to cirrhosis in the region, followed by alcohol consumption (20·8%), non-alcoholic fatty liver disease (NAFLD; 12·1%), and chronic infection with hepatitis C virus (HCV; 15·7%). In 2015, HBV accounted for about half the cases of hepatocellular carcinoma in the region. Preventive…
Citation impact
- FWCI
- 35.45
- Percentile
- 100%
- References
- 337
Authors
20- SKShiv Kumar SarinCorresponding
Institute of Liver and Biliary Sciences
- MKManoj Kumar
Institute of Liver and Biliary Sciences
- MEMohammed Eslam
The University of Sydney, Westmead Institute for Medical Research, Westmead Institute, Westmead Hospital
- JGJacob George
The University of Sydney, Westmead Institute for Medical Research, Westmead Institute, Westmead Hospital
- MAMamun Al Mahtab
Bangladesh Medical University
Topics & keywords
- Medicine
- Hepatocellular carcinoma
- Hepatology
- Internal medicine
- Liver disease
- Viral hepatitis
- Population
- Cirrhosis
Funding
- MMMetropolitan Museum of Art
- ICIndian Council of Medical Research
- IDIndia Diabetes Research Foundation
- UOUniversity of Sydney
- AIAll-India Institute of Medical Sciences
- MRMedical Research Council
- NHNational Health and Medical Research CouncilAwards: APP1108422, APP1107178, 1053206
- SMSydney Medical School Foundation